Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT

Journal of Nuclear Cardiology

Volumn 23, Issue 3, 2016, Pages 425-435

  Clements, Ian P ^a   Garcia, Ernest V ^b   Chen, Ji ^b   Folks, Russell D ^c   Butler, Javed ^b   Jacobson, Arnold F ^d  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d GE Health Care   (United States)

Author keywords

heart failure; MIBG imaging; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; TETROFOSMIN TC 99M; (3 IODOBENZYL)GUANIDINE; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC-99M TETROFOSMIN;

ADULT; AGED; ARTICLE; AUTOMATION; CARDIAC IMAGING; CARDIAC PATIENT; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INNERVATION; HEART MUSCLE PERFUSION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION STUDY; AUTOMATED PATTERN RECOGNITION; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; ETIOLOGY; EVALUATION STUDY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; IMAGE ENHANCEMENT; MACHINE LEARNING; MIDDLE AGED; MULTIMODAL IMAGING; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; VERY ELDERLY;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MACHINE LEARNING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84925250035     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-015-0097-4     Document Type: Article

References (40)

1. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992;33:471-7.
2. Merlet P, Benvenuti C, Moyse D, Proicuillart F, Dubois-Rande JL, Duval AM, et al. Prognostic value of I123-mIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23.
3. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BLF. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J 2008;29:1147-59.
4. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.
5. Kawaguchi T, Nomura M, Tujikawa T, Nakaya Y, Ito S. 123I-metaiodo-benzylguanidine myocardial scintigraphy in the Brugada-type ECG. J Med Invest 2006;53:95-102.
6. Paul M, Schafers M, Kies P, Acil T, Schäfers K, Breithardt G, et al. Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 2006;33:866-70.
7. Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Schulze-Bahr E, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002;105:702-6.
8. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simões MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011;52:504-10.
9. Gill JS, Hunter GJ, Gane G, Camm AJ. Asymmetry of I123-mIBG scans in patients with VT and a “normal” heart. Br Heart J 1993;69:6-13.
10. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990;82:1095-105.
11. Stanton MS, Zipes DP. Modulation of drug effects by regional sympathetic denervation and supersensitivity. Circulation 1991;84:1709-14.
12. Boogers MJ, Borleffs CJW, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.
13. Bax JJ, Kraft O, Buxton AE, Fjeld JK, Parízek P, Agostini D, et al. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: A prospective multicenter pilot study. Circ Cardiovasc Imaging 2008;1:131-40.
14. Arora R, Ferrick KJ, Nakata T, Kaplan RC, Rozengarten M, Latif F, et al. 123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter-defibrillator. J Nucl Cardiol 2003;10:121-31.
15. Zhao C, Shuke N, Yamamoto W, Okizaki A, Sato J, Ishikawa Y, et al. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. J Nucl Med 2001;42:1017-24.
16. Gill JS, Hunter GJ, Gane G, Camm AJ. Heterogeneity of the human myocardial sympathetic innervation: In vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993;126:390-8.
17. Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schaffers M, et al. Proposal for standardization of 123 I metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EAMN Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.
18. Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV. Quantitative I-123 MIBG SPECT in differentiating abnormal and normal I123-mIBGmyocardial uptake. J Nucl Cardiol 2012;19:92-9.
19. Jacobson AF, Lombard J, Banerjee G, Camici PG. I123-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol 2009;16:113-21.
20. Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: A systematic review and meta-analysis. Circ Cardiovasc Imaging 2014;7:250-8.
21. Paterson I, Mielniczuk LM, O’Meara E, So A, White JA. Imaging heart failure: Current and future applications. Can J Cardiol 2013;29:317-28.
22. McArdle B, Dowsley TF, Cocker MS, Ohira H, deKemp RA, DaSilva J, et al. Cardiac PET: Metabolic and functional imaging of the myocardium. Semin Nucl Med 2013;43:434-48.
23. Rischpler C, Nekolla S, Schwaiger M. PET and SPECT in heart failure. Current Cardiol Rep 2013;15:337.
24. Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging 2013;6:1327-41.
25. Notghi A, Low CS. Myocardial perfusion scintigraphy: Past, present and future. Br J Radiol 2011;84:S229-36.
26. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Improved quantification in 123-I cardiac SPECT imaging with deconvolution of septal penetration. Nucl Med Commun 2006;27:551-8.
27. Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H, et al. Quantitative same-day rest-stress technetium-99m-Sestamibi SPECT: Definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494-502.
28. Garcia EV, Faber TL, Cooke CD, Folks RD, Chen J, Santana C. The increasing role of quantification in nuclear cardiology: The Emory approach. J Nucl Cardiol 2007;14:420-32.
29. Maddahi J, Van Train K, Prigent F, Garcia EV, Friedman J, Ostrzega E, et al. Quantitative single photon emission computed thallium-201 tomography for detection and localization of coronary artery disease: Optimization and prospective validation of a new technique. J Am Coll Cardiol 1989;14:1689-99.
30. DePuey EG, Roubin GS, DePasquale EE, Nody AC, Garcia EV, King SB, et al. Sequential multivessel coronary angioplasty assessed by thallium-201 tomography. Cathet Cardiovasc Diagn 1989;18:213-21.
31. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
32. Garcia EV, Cooke CD, Van Train K, Folks R, Peifer J, DePuey G, et al. Technical aspects of myocardial SPECT imaging with Tc-99m sestamibi. Am J Cardiol 1990;66:23E-31E.
33. Santana CA, Faber TL, Soler-Peter M, Sanyala R, Estevesa FP, Ornelasa M, et al. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment. Nucl Med Commun 2008;29:970-81.
34. Botvinick EH, Dunn RF, Hattner RS, Massie BM. A consideration of factors affecting the diagnostic accuracy of thallium-201 myocardial perfusion scintigraphy in detecting coronary artery disease. Semin Nucl Med 1980;10:157-67.
35. Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol 2006;13:251-60.
36. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981;22:129-32.
37. Wafelman AR, Hoefnagel CA, Maes RA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: A review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 1994;21:545-59.
38. Fintel DJ, Links JM, Brinker JA, Frank TL, Parker M, Becker LC. Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: A receiver operating characteristic analysis. J Am Coll Cardiol 1989;13:600-12.
39. Slomka P, Xu Y, Berman D, Germano G. Quantitative analysis of perfusion studies: Strengths and pitfalls. J Nucl Cardiol 2012;19:338-46.
40. Luisi AJ, Fallavollita JA, Suzuki G, Canty JM. Spatial inhomogeneity of sympathetic nerve function in hibernating myocardium. Circulation 2012;106:779-81.